Financials Observe Medical ASA

Equities

OBSRV

NO0010865009

Medical Equipment, Supplies & Distribution

Market Closed - Oslo Bors 10:45:00 2024-04-30 am EDT 5-day change 1st Jan Change
0.516 NOK -0.77% Intraday chart for Observe Medical ASA +29.00% +58.04%

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 179.3 271.5 386.2 127.8
Enterprise Value (EV) 1 204.5 287.8 438.8 160.9
P/E ratio -8.72 x -6.23 x -14.7 x -2.21 x
Yield - - - -
Capitalization / Revenue 1,015 x 91.7 x 16.1 x 6.55 x
EV / Revenue 1,158 x 97.2 x 18.3 x 8.24 x
EV / EBITDA -15.8 x -11.5 x -14.1 x -3.16 x
EV / FCF -19,826,261 x -17,050,843 x -26,676,343 x -6,196,416 x
FCF Yield -0% -0% -0% -0%
Price to Book 12.3 x 13.3 x -27.3 x 0.92 x
Nbr of stocks (in thousands) 15,068 19,605 19,605 53,492
Reference price 2 11.90 13.85 19.70 2.390
Announcement Date 4/30/20 4/30/21 4/29/22 4/28/23
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022
Net sales 1 0.1062 0.1766 2.961 24.04 19.52
EBITDA 1 -8.832 -12.94 -25.11 -31.1 -50.94
EBIT 1 -11.72 -15.79 -26.88 -31.92 -58.48
Operating Margin -11,041.04% -8,936.68% -907.67% -132.79% -299.56%
Earnings before Tax (EBT) 1 2.274 -16.92 -36.87 -26.32 -50.72
Net income 1 2.274 -16.92 -36.87 -26.32 -50.8
Net margin 2,141.22% -9,576.73% -1,245.12% -109.48% -260.24%
EPS 2 0.1916 -1.364 -2.224 -1.343 -1.080
Free Cash Flow - -10.32 -16.88 -16.45 -25.97
FCF margin - -5,839.34% -570.06% -68.42% -133.03%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 4/30/20 4/30/20 4/30/21 4/29/22 4/28/23
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt 1 24.4 25.2 16.3 52.6 33.1
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) -2.764 x -1.949 x -0.648 x -1.691 x -0.6492 x
Free Cash Flow - -10.3 -16.9 -16.4 -26
ROE (net income / shareholders' equity) - -108% -211% -845% -81.8%
ROA (Net income/ Total Assets) - -17.3% -23.5% -25% -25.4%
Assets 1 - 97.87 157 105.2 199.8
Book Value Per Share 2 1.420 0.9700 1.040 -0.7200 2.590
Cash Flow per Share 2 0.0500 0.0300 0.9700 0.1500 0.2600
Capex - - 1.24 4.89 1.4
Capex / Sales - - 41.84% 20.32% 7.19%
Announcement Date 4/30/20 4/30/20 4/30/21 4/29/22 4/28/23
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. OBSRV Stock
  4. Financials Observe Medical ASA